サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555527

認知診断市場：診断別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Cognitive Diagnostics Market, By Diagnosis, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
認知診断市場：診断別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

2023年の認知診断の市場規模は53億9,021万米ドルで、2024年から2032年にかけてCAGR 27.90%で拡大

認知診断市場-市場力学

世界の高齢人口の増加と認知障害の有病率の増加が市場成長の原動力となる見込み

世界の人口動態は急速な高齢化傾向にあり、高齢者人口の増加が顕著です。この人口動態の変化により、高齢者はアルツハイマー病や様々な認知症を含む認知障害のリスクが高まっています。世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上になると予測しています。その結果、60歳以上の人口は2020年の10億人から14億人に増加すると予想されています。認知障害の認知度向上と診断方法の進歩は、認知障害の特定率の向上に寄与しています。診断技術の進化に伴い、より多くの症例が認識され、より早い段階で診断されるようになっています。さらに、現在進行中の技術革新と医療インフラの拡充は、市場成長の大きな機会となっています。とはいえ、標準化が進んでいないことが、市場拡大に課題をもたらす可能性もあります。

認知診断市場-主要インサイト

調査アナリストの分析によると、世界市場は予測期間（2024-2032年）においてCAGR約27.90％で成長すると推定されます。

地域別では、北米が2023年に収益でリードしました。

認知診断市場-セグメンテーション分析：

世界の認知診断市場は、診断、適応症、エンドユーザー、地域に基づいてセグメント化されます。

脳画像検査、臨床検査、精神状態検査、迅速ホームスクリーニング検査、神経心理学的検査、脳波（EEG）、認知機能・行動検査、NPI-Q（Neuropsychiatric Inventory Questionnaire）。これらの診断カテゴリーはそれぞれ、徹底的な評価を提供し、認知健康の領域で患者の転帰を向上させるために不可欠です。

市場は適応症別に2つのカテゴリーに分類される：アルツハイマー病、認知症、その他の神経疾患です。各カテゴリーには、これらの疾患を評価・治療するための明確な診断ツールや方法が含まれます。

エンドユーザー別では、病院、神経科クリニック、リハビリセンター、学術・研究機関、在宅ケア、その他に分類されます。各エンドユーザーグループは、特定の要件や環境に合わせてカスタマイズされた異なる診断ツールや技術を採用しています。

認知診断市場-地理的洞察

市場は地理的に北米、中南米、欧州、アジア太平洋、中東・アフリカに広がっています。これらの地域は、ビジネス上の目的からさらに国別に区分されています。北米は、認知能力を評価するための診断ツールや技術に対する需要の増加により、市場の成長をリードしています。同地域は、特に人工知能（AI）と機械学習における技術進歩のパイオニアです。これらの技術は認知診断ツールに組み込まれ、その精度と有効性を向上させています。ピュー・リサーチが実施した調査によると、米国人の55％がAIを定期的に使用していると主張する一方、44％は定期的に使用していないと考えていることが明らかになった。欧州は、個別化医療に対する需要の高まりに起因して、市場成長の第2位の地域となっています。

コグニティブ診断市場-競争環境：

認知診断市場は熾烈な競争状態にあり、幅広い競合企業が技術的進歩、戦略的提携、製品の差別化を通じて市場シェアの獲得に努めています。各社は、革新的な診断機器や技術を導入するための研究開発に多大なリソースを投入しています。これには、脳画像、バイオマーカー分析、AIを活用した診断システムの進歩が含まれます。企業は、新興市場に進出し、認知診断の需要が高まっている地域でプレゼンスを確立することで、市場範囲を広げています。これには、新たな施設の設立、現地企業の買収、地域の要件に合わせた製品のカスタマイズなどが含まれます。各社は、ユニークな診断機器の開発、精度の向上、ユーザーフレンドリーなインターフェイス、他のヘルスケア技術とのシームレスな統合により、他社との差別化を図っています。これには、認知評価の様々な側面に対応する包括的な診断ソリューションの提供も含まれます。

目次

第1章 認知診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 認知診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 認知診断産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 認知診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 認知診断市場情勢

  • 認知診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 認知診断市場- 診断別

  • 概要
    • 診断別セグメントシェア分析
    • 脳画像検査
      • 磁気共鳴画像（MRI）
      • コンピュータ断層撮影（CT）
      • 陽電子放出断層撮影（PET）とPET/CT
    • 臨床検査
      • 脳脊髄液（CSF）
      • 血液検査
    • 精神状態検査
      • ミニメンタルステート検査（MMSE）
      • モントリオール認知評価（MoCA）
    • 迅速な家庭用スクリーニング検査
    • 神経心理学的検査
    • 脳波（EEG）
    • 認知機能と行動テスト
    • 神経精神医学的質問票（NPI-Q）

第8章 認知診断市場- 適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • アルツハイマー病
    • 痴呆
    • その他の神経疾患

第9章 認知診断市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 神経科クリニック
    • リハビリテーションセンター
    • 学術調査機関
    • ホームケア
    • その他

第10章 認知診断市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 認知診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Cognetivity Neurosciences
    • Cognivue
    • Cogstate
    • Cambridge Cognition
    • Diadem
    • CN Diagnostics
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3591

REPORT HIGHLIGHT

Cognitive Diagnostics Market size was valued at USD 5,390.21 million in 2023, expanding at a CAGR of 27.90% from 2024 to 2032.

Cognitive diagnostic models are a psychometric paradigm for designing and scoring tests to provide a profile of examinee skill mastery rather than just an overall test score. Cognitive diagnostics refers to the assessment and evaluation of cognitive functions, which include memory, attention, language, problem-solving, and other intellectual abilities. This field encompasses various techniques, tools, and technologies used to diagnose cognitive impairments and disorders, such as Alzheimer's disease, dementia, ADHD, and other neurological conditions. Cognitive diagnostics play a crucial role in the management and treatment of cognitive disorders, offering valuable insights into brain health and function. As technology advances, the field is expected to grow, providing more accurate, accessible, and affordable diagnostic options.

Cognitive Diagnostics Market- Market Dynamics

The growing geriatric population and increasing prevalence of cognitive disorders globally are expected to drive the growth of the market

The global demographic landscape is experiencing a swift aging trend, marked by a notable rise in the elderly population. This demographic shift places older adults at an elevated risk for cognitive impairments, including Alzheimer's disease and various forms of dementia. The World Health Organization projects that by the year 2030, one in six individuals worldwide will be aged 60 years or older. Consequently, the population segment aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion. Enhanced awareness and advancements in diagnostic methods are contributing to higher rates of identification for cognitive disorders. As diagnostic technologies evolve, more cases are being recognized and diagnosed at earlier stages-additionally, the ongoing technological innovations and the expansion of healthcare infrastructure present significant opportunities for market growth. Nevertheless, the absence of standardization may pose challenges to the market's expansion.

Cognitive Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 27.90% over the forecast period (2024-2032)

Based on region, North America was the leading revenue generator in 2023

Cognitive Diagnostics Market- Segmentation Analysis:

The Global Cognitive Diagnostics Market is segmented based on Diagnosis, Indication, End-User, and Region.

The market is segmented into eight distinct categories according to Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function & Behavioral Tests, and the Neuropsychiatric Inventory Questionnaire (NPI-Q). Each of these diagnostic categories is essential for delivering thorough evaluations and enhancing patient outcomes in the realm of cognitive health.

The market is segmented into two categories according to Indication: Alzheimer's disease, Dementia, and other neurological disorders. Each category includes distinct diagnostic tools and methods for evaluating and treating these conditions.

The market is segmented into two groups according to End-User: Hospitals, Neurology Clinics, Rehabilitation Centers, Academic and Research Institutes, Home Care, and Others. Each end-user group employs different diagnostic tools and techniques customized to their particular requirements and environments.

Cognitive Diagnostics Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market growth, driven by the increasing demand for diagnostic tools and technologies to assess cognitive performance. The region is a pioneer in technological advancements, especially in artificial intelligence (AI) and machine learning. These technologies are being incorporated into cognitive diagnostic tools, improving their precision and effectiveness. A survey conducted by Pew Research revealed that 55% of Americans claim to regularly use AI, while 44% believe they do not use it regularly. Europe follows as the second largest region for market growth, attributed to the rising demand for Personalized Medicine.

Cognitive Diagnostics Market- Competitive Landscape:

The cognitive diagnostics market is fiercely competitive, with a wide array of competitors striving to gain market share through technological advancements, strategic alliances, and product distinctiveness. Organizations are dedicating significant resources to research and development to introduce innovative diagnostic instruments and technologies. This encompasses progress in brain imaging, biomarker analysis, and AI-powered diagnostic systems. Businesses are broadening their market reach by venturing into emerging markets and establishing a presence in regions where there is a growing demand for cognitive diagnostics. This involves establishing new facilities, acquiring local entities, and customizing products to suit regional requirements. Companies set themselves apart by creating unique diagnostic instruments, enhancing precision, user-friendly interfaces, and seamless integration with other healthcare technologies. This includes providing comprehensive diagnostic solutions that address various aspects of cognitive evaluation.

Recent Developments:

C2N Diagnostics, a prominent entity in the field of advanced brain health diagnostics known for its PrecivityAD blood test, which assists in the diagnosis of Alzheimer's disease, has unveiled its latest innovative product. This new offering is expected to significantly improve care for individuals experiencing cognitive impairment: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) designated for Research Use Only (RUO).

Cognetivity Neurosciences Ltd., a technology company specializing in brain health screening platforms for medical, commercial, and consumer settings, is excited to share that its leading CognICA tool has proven to be effective in monitoring cognitive function in Alzheimer's disease patients undergoing treatment with the disease-modifying therapy Aduhelm (aducanumab) from Biogen.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COGNITIVE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Cognetivity Neurosciences
  • Cognivue
  • Cogstate
  • Cambridge Cognition
  • Diadem
  • CN Diagnostics
  • Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

  • Brain Imaging Tests
  • Magnetic Resonance Imaging (MRI)
  • Computerized Tomography (CT)
  • Positron Emission Tomography (PET) and PET/CT
  • Laboratory Testing
  • Cerebrospinal fluid (CSF)
  • Blood Tests
  • Mental Status Testing
  • Mini-Mental State Exam (MMSE)
  • Montreal Cognitive Assessment (MoCA)
  • Rapid Home Screening Tests
  • Neuropsychological Testing
  • Electroencephalogram (EEG)
  • Cognitive Function & Behavioral Tests
  • Neuropsychiatric Inventory Questionnaire (NPI-Q)
  • GLOBAL COGNITIVE DIAGNOSTICS MARKET, INDICATION BY - MARKET ANALYSIS, 2019 - 2032
  • Alzheimer's disease
  • Dementia
  • Others neurological disorders

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Neurology Clinics
  • Rehabilitation Centers
  • Academic and Research Institutes
  • Home Care
  • Others

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cognitive Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cognitive Diagnostics Market Snippet by Diagnosis
    • 2.1.2. Cognitive Diagnostics Market Snippet by Indication
    • 2.1.3. Cognitive Diagnostics Market Snippet by End-User
    • 2.1.4. Cognitive Diagnostics Market Snippet by Country
    • 2.1.5. Cognitive Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Cognitive Diagnostics Key Market Trends

  • 3.1. Cognitive Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cognitive Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cognitive Diagnostics Market Opportunities
  • 3.4. Cognitive Diagnostics Market Future Trends

4. Cognitive Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cognitive Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cognitive Diagnostics Market Landscape

  • 6.1. Cognitive Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cognitive Diagnostics Market - By Diagnosis

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
    • 7.1.2. Brain Imaging Tests
      • 7.1.2.1. Magnetic Resonance Imaging (MRI)
      • 7.1.2.2. Computerized Tomography (CT)
      • 7.1.2.3. Positron Emission Tomography (PET) and PET/CT
    • 7.1.3. Laboratory Testing
      • 7.1.3.1. Cerebrospinal fluid (CSF)
      • 7.1.3.2. Blood Tests
    • 7.1.4. Mental Status Testing
      • 7.1.4.1. Mini-Mental State Exam (MMSE)
      • 7.1.4.2. Montreal Cognitive Assessment (MoCA)
    • 7.1.5. Rapid Home Screening Tests
    • 7.1.6. Neuropsychological Testing
    • 7.1.7. Electroencephalogram (EEG)
    • 7.1.8. Cognitive Function & Behavioral Tests
    • 7.1.9. Neuropsychiatric Inventory Questionnaire (NPI-Q)

8. Cognitive Diagnostics Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Alzheimer's disease
    • 8.1.3. Dementia
    • 8.1.4. Others neurological disorders

9. Cognitive Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Neurology Clinics
    • 9.1.4. Rehabilitation Centers
    • 9.1.5. Academic and Research Institutes
    • 9.1.6. Home Care
    • 9.1.7. Others

10. Cognitive Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cognitive Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cognitive Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cognitive Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Cognitive Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Cognitive Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Cognitive Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Cognetivity Neurosciences
    • 11.2.2. Cognivue
    • 11.2.3. Cogstate
    • 11.2.4. Cambridge Cognition
    • 11.2.5. Diadem
    • 11.2.6. CN Diagnostics
    • 11.2.7. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us